Who
Igor Matushansky
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Immuneering; Chief Medical Officer, HOOKIPA Pharma.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $634K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 17 Apr 2019
- Last trade
- 3 Feb 2026
- Last filed
- 5 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 21 Mar 2025filed 24 Mar 2025 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,000 at $0.00 | filing |
| 30 Jun 2022filed 1 Jul 2022 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —92,950 at $0.00 | filing |
| 19 Apr 2022filed 20 Apr 2022 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —92,950 at $0.00 | filing |
| 1 Feb 2022filed 1 Feb 2022 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | $75K24,888 at $3.00 | filing |
| 1 Feb 2022filed 1 Feb 2022 | HOOKIPA Pharma | SEC FORM 4 Code A | $45K14,933 at $3.00 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code M | —8,079 at $0.00 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code M | —11,366 at $0.00 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code M | —3,408 at $0.00 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharma | SEC FORM 4 Code M | $8088,079 at $0.10 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharma | SEC FORM 4 Sold | $13K5,304 at $2.49 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharma | SEC FORM 4 Code M | $1,13711,366 at $0.10 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharma | SEC FORM 4 Sold | $19K7,440 at $2.49 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharma | SEC FORM 4 Code M | $3413,408 at $0.10 | filing |
| 21 Dec 2021filed 12 Jan 2022 | HOOKIPA Pharma | SEC FORM 4 Sold | $5,4902,205 at $2.49 | filing |
| 19 Apr 2021filed 21 Apr 2021 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —95,250 at $0.00 | filing |
| 17 Dec 2020filed 18 Dec 2020 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code M | —31,656 at $0.00 | filing |
| 17 Dec 2020filed 18 Dec 2020 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code M | —11,367 at $0.00 | filing |
| 17 Dec 2020filed 18 Dec 2020 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code M | —5,965 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.